JPRN-UMIN000014790已完成未知
Investigation of the efficacy and safety of ipragliflozin combination therapy in case of insufficient glycemic control by DPP-4 inhibitors - Investigation of the efficacy and safety of ipragliflozin combination therapy in case of insufficient glycemic control by DPP-4 inhibitors
Japan Community Health care Organization Kanazawa Hospital0 个研究点目标入组 30 人开始时间: 2014年8月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetes 2) With severe ketosis, diabetic coma, or precoma 3) With severe infection, pre or post surgery, and serious trauma 4) With severe hepatic dysfunction (Over grade 3 in classification criteria for severity of adverse drug reactions) 5) With moderate or severe renal dysfunction (Serum Creatinine male: >= 1.5mg/dL, female: >= 1.3mg/dL) 6) Has stroke, myocardial infarction, or other serious cardiovascular complications requireing hospitalization within 6 months 7) Is receiving SGLT-2 inhibitors, GLP-1 antagonists, or insulin therapy at consent 8) Is nursing or pregnant or planned to become pregnant 9) With hypersensitivity to ipragliflozin or any other excipient of ipragliflozin 10) Considered as inadequate by the investigator
研究者
相似试验
已完成
不适用
Investigation of the efficacy and safety of ipragliflozin in obese patients with type 2 diabetes undergoing metformin (Met)Type 2 diabetesJPRN-UMIN000014638Association of medical corporation Toyukai, Yutenji Medical Clinic35
已完成
不适用
A study on the efficacy and safety of ipragliflozin monotherapy or combination therapy under clinical use condition: continuous glucose monitoring and self monitoring of urine glucoseType 2 diabetesJPRN-UMIN000014388Kato clinic of Internal medicine30
招募中
不适用
Investigation of clinical efficacy and safety of intramuscular administration of autologous total IgG therapy in patients with chronic urticariaDiseases of the skin and subcutaneous tissueKCT0006814Ajou University Hospital24
进行中（未招募）
1 期
Clinical study assessing safety and efficacy of Istaroxime in patients affected by acute cardiac insufficiency decompensated. Five centres will be involved. Each patient will receive, in a casual order, one of the two Istaroxime dosages or placebo and therefore there will be three different treatment groups. Nor the patients neither the doctors will know the treatment received/administered.EUCTR2013-000540-26-ITCVie Therapeutics Company Limited120
已完成
不适用
Evaluation for efficacy and safety of Irsogladine maleate for oral lichen planusoral lichen planusJPRN-UMIN000008735Faculty of Medicine, Kagawa University40